期刊语言：英语

出版地区：美国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：

https://ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=6221039

3、投稿网址：

http://mc.manuscriptcentral.com/embs-ieee

4、官网邮箱：pamela.bhatti@ece.gatech.edu（主编）

kara@health.embs.org（总编）

5、官网电话：832-776-8089（总编）

6、出刊日期：年刊，一年出版1期。

2021年10月28日星期四

投稿须知【官网信息】

Instructions for Authors

Submit articles for publication in JTEHM through ScholarOne Manuscripts. All submissions must follow the IEEE JTEHM templates. Upon acceptance, authors are encouraged to include either a video abstract or a high-resolution image for both Xplore and JTEHM.

A length of 8 pages of text, including references, is recommended for papers. Communication manuscripts are limited to 5 pages (4 for text and 1 for acknowledgment and references). Supplemental material does not count toward the page length.

As a Gold Open Access journal, JTEHM charges article processing fees of US $1750 with discounts for IEEE Members (5%), IEEE Society Members (15%), and EMBS Members (25%). The discounts cannot be combined. Corresponding authors from low-income countries (as classified by the World Bank) may be eligible for discounts or fee waivers. Eligible authors of accepted papers should contact the editor-in-chief.

More Information can be found in our FAQs.

Author Instructions for Manuscript Preparation

August 2020

JTEHM publishes translational research papers and findings in all stages of technology translation to healthcare and clinical applications, emphasizing expected or demonstrated impact in patient care and medical practice. JTEHM welcomes submission of all types of translational research falling upon the spectrum explained below.

The articles in this journal are peer reviewed in accordance with the requirements set forth in the IEEE Publication Services and Products Board Operations Manual. Each published article is reviewed by a minimum of two independent reviewers using a single-blind peer review process, where the identities of the reviewers are not known to the authors, but the reviewers know the identities of the authors. Submitted articles are screened for plagiarism before review.

Word Choice

We prefer that authors use inclusive language. For example, please use non gendered terms when possible, and replace the terms “master” and “slave” with “parent” and “child” or “primary” and “replica.”

Manuscript Types

Papers

These manuscripts have a length of up to 8 pages of text, including references (8 pages is recommended).  Papers of 9-10 pages incur an overlength charge of US$250/page, and US$350 is charged for each page over 10.  Papers must include the sections below.  Download the paper template. Download the LaTex version of the paper template.

Structured Abstract: Limited to 250 words with the following headings (headings do not contribute to the word count).

Objective

Methods

Results

Discussion/Conclusion

Index Terms: Up to 5 keywords in alphabetical order.

Clinical and Translational Impact Statement: An impact statement of no more than 30 words. The statement should address how the reported findings serve to improve human health (or provide a path to improving health), and articulate a strategy for how the reported device, diagnostic, therapeutic, or service may be integrated into a clinical or home healthcare setting. The authors are encouraged to review the NIH Clinical Spectrum (see below) and indicate the best category for the reported work: Early/Pre-Clinical Research, Clinical Research, Clinical Implementation, or Public Health. Any submission without this statement will be returned to the author without review.

Body: The main manuscript body.  This is organized at the author(s)’ discretion with the exception of the following main headings.

Introduction

Methods and Procedures

Results

Conclusion

References

Acknowledgments and Appendices/supplemental material (not required, but encouraged)

Communications

Short manuscripts of 5 pages maximum (4 for text and 1 for acknowledgment and references).  Communications may be peer reviewed through the normal process; or they may follow an expedited review process at the Editor-in-Chief’s discretion.  Ideal Communications are accompanied by additional material such as video, databases, and executable codes of any models as provided by the authors. Communications should report on new results on novel technologies in early translational development phase, early clinical implementation and validation, or discussion of emerging challenges and unmet needs.  Download the Communication template.

Structured Abstract: Limited to 150 words with the following headings (headings do not contribute to the word count):

Objective

Methods

Results

Discussion/Conclusion

Index Terms: Up to 5 keywords in alphabetical order.

Clinical and Translational Impact Statement: An impact statement of no more than 30 words. The statement should address how the reported findings serve to improve human health (or provide a path to improving health), and articulate a strategy for how the reported device, diagnostic, therapeutic, or service may be integrated into a clinical or home healthcare setting. The authors are encouraged to review the NIH Clinical Spectrum (See Below) and indicate the best category for the reported work: Early/Pre-Clinical Research, Clinical Research, Clinical Implementation, or Public Health. Any submission without this statement will be returned to the author without review.

Body: The main manuscript body organized in the following manner.

Introduction and Clinical Need

Results

Discussion

Methods

Future Directions and Potential Clinical Impact

Acknowledgment (not required, but encouraged)

Appendix/Supplemental Material (if desired)

Letter to the Editor

A Letter to the Editor is a brief report or commentary that is within the journal’s scope and of particular interest to the community, but not suitable as a standard research article. It can represent the opinion of an individual or a small group of individuals/stakeholders. Letters must be limited to 500 words and will be published on the JTEHM website without any open-access publication fee.

Letters to the Editor may be edited for clarity or length and may be subject to peer review at the Editors’ discretion. To contribute, please contact the Editor-in-Chief.

……

更多详情：

https://www.embs.org/jtehm/instructions-for-authors/